These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 3018542)

  • 21. The effects of nerve growth factor on polyamine metabolism in PC12 cells.
    Guroff G; Dickens G
    J Neurochem; 1983 May; 40(5):1271-7. PubMed ID: 6601181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The action of adenosine analogs on PC12 cells.
    Guroff G; Dickens G; End D; Londos C
    J Neurochem; 1981 Dec; 37(6):1431-9. PubMed ID: 7334372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nerve growth factor treatment or cAMP elevation reduces Ca2+/calmodulin-dependent protein kinase III activity in PC12 cells.
    Nairn AC; Nichols RA; Brady MJ; Palfrey HC
    J Biol Chem; 1987 Oct; 262(29):14265-72. PubMed ID: 2443502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutants of PC12 cells with altered cyclic AMP responses.
    Block T; Kon C; Breckenridge BM
    Mol Cell Biol; 1984 Oct; 4(10):2091-7. PubMed ID: 6095039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 8-Cl-cAMP induces truncation and down-regulation of the RI alpha subunit and up-regulation of the RII beta subunit of cAMP-dependent protein kinase leading to type II holoenzyme-dependent growth inhibition and differentiation of HL-60 leukemia cells.
    Rohlff C; Clair T; Cho-Chung YS
    J Biol Chem; 1993 Mar; 268(8):5774-82. PubMed ID: 8449943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of fibroblast growth factor on PC12 cells.
    Togari A; Dickens G; Kuzuya H; Guroff G
    J Neurosci; 1985 Feb; 5(2):307-16. PubMed ID: 2983039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PC12 cell mutants that possess low- but not high-affinity nerve growth factor receptors neither respond to nor internalize nerve growth factor.
    Green SH; Rydel RE; Connolly JL; Greene LA
    J Cell Biol; 1986 Mar; 102(3):830-43. PubMed ID: 3005338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic induction of ornithine decarboxylase by diacylglycerol, A23187, and cholera toxin in guinea pig lymphocytes.
    Otani S; Matsui-Yuasa I; Hashikawa K; Kasai S; Matsui K; Morisawa S
    Biochem Biophys Res Commun; 1985 Jul; 130(1):389-95. PubMed ID: 2992466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations that prevent cyclic nucleotide binding to binding sites A or B of type I cyclic AMP-dependent protein kinase.
    Ogreid D; Døskeland SO; Gorman KB; Steinberg RA
    J Biol Chem; 1988 Nov; 263(33):17397-404. PubMed ID: 2846564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-transcriptional regulation of cAMP-dependent protein kinase activity by cAMP in GH3 pituitary tumor cells. Evidence for increased degradation of catalytic subunit in the presence of cAMP.
    Richardson JM; Howard P; Massa JS; Maurer RA
    J Biol Chem; 1990 Aug; 265(23):13635-40. PubMed ID: 2166038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclic AMP-dependent protein kinase mediates a cyclic AMP-stimulated decrease in ornithine and S-adenosylmethionine decarboxylase activities.
    Insel PA; Fenno J
    Proc Natl Acad Sci U S A; 1978 Feb; 75(2):862-5. PubMed ID: 204937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells.
    Chijiwa T; Mishima A; Hagiwara M; Sano M; Hayashi K; Inoue T; Naito K; Toshioka T; Hidaka H
    J Biol Chem; 1990 Mar; 265(9):5267-72. PubMed ID: 2156866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nerve growth factor acts through cAMP-dependent protein kinase to increase the number of sodium channels in PC12 cells.
    Kalman D; Wong B; Horvai AE; Cline MJ; O'Lague PH
    Neuron; 1990 Mar; 4(3):355-66. PubMed ID: 1690563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A nerve growth factor-sensitive S6 kinase in cell-free extracts from PC12 cells.
    Matsuda Y; Nakanishi N; Dickens G; Guroff G
    J Neurochem; 1986 Dec; 47(6):1728-34. PubMed ID: 3772374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between NGF-mediated volume increase and "priming effect" in fast and slow reacting clones of PC12 pheochromocytoma cells. Role of cAMP.
    Heumann R; Kachel V; Thoenen H
    Exp Cell Res; 1983 Apr; 145(1):179-90. PubMed ID: 6303817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NIF (neurite-inducing factor): a novel peptide inducing neurite formation in PC12 cells.
    Wagner JA
    J Neurosci; 1986 Jan; 6(1):61-7. PubMed ID: 3511190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Turnover of regulatory subunit of cyclic AMP-dependent protein kinase in S49 mouse lymphoma cells. Regulation by catalytic subunit and analogs of cyclic AMP.
    Steinberg RA; Agard DA
    J Biol Chem; 1981 Nov; 256(21):10731-4. PubMed ID: 6270127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of two mutants of the LLC-PK1 porcine kidney cell line affected in the catalytic subunit of the cAMP-dependent protein kinase.
    Botterell SH; Jans DA; Hemmings BA
    Eur J Biochem; 1987 Apr; 164(1):39-44. PubMed ID: 2435550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple pathways of N-kinase activation in PC12 cells.
    Rowland-Gagné E; Greene LA
    J Neurochem; 1990 Feb; 54(2):423-33. PubMed ID: 2153751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the dominance of mutations in cAMP-binding sites of murine type I cAMP-dependent protein kinase in activation of kinase from heterozygous mutant lymphoma cells.
    Shuntoh H; Steinberg RA
    J Cell Physiol; 1991 Jan; 146(1):86-93. PubMed ID: 1846638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.